DOI:

10.37988/1811-153X_2026_1_164

Characteristics of dentofacial anomalies in patients with acromegaly

Authors

  • A.R. Khasanov 1, postgraduate at the Maxillofacial and plastic surgery Department
    ORCID: 0009-0004-0639-022X
  • L.K. Dzeranova 2, Doctor of Science in Medicine, full, chief researcher
    ORCID: 0000-0002-0327-4619
  • E.A. Pigarova 2, Doctor of Science in Medicine, professor, director of the Institute of postgraduate education
    ORCID: 0000-0001-6539-466X
  • E.A. Melikov 1, PhD in Medical Sciences, assistant professor of the Maxillofacial and plastic surgery Department
    ORCID: 0000-0001-5173-6956
  • A.Yu. Drobyshev 1, Doctor of Science in Medicine, full professor of the Maxillofacial and plastic surgery Department
    ORCID: 0000-0002-1710-6923
  • 1 Russian University of Medicine, 127473, Moscow, Russia
  • 2 Endocrinology Research Center, 117292, Moscow, Russia

Abstract

Acromegaly is a systemic disease affecting all body structures. The main focus of treatment is the restoration of hormonal levels. However, emerging morphological changes in the maxillary system may require the involvement of specialists from dentistry and maxillofacial surgery.
Materials and methods.
The study involved 40 patients with acromegaly aged 18 and over, 20 men and 20 women. Patients undergoing drug treatment for pituitary adenoma (correction of GH and/or insulin-like growth factor type 1 (IGF-1) levels) were included. The patients underwent a general clinical examination, computed tomography of the facial bones, and additionally examined the condition of the temporomandibular joint (TMJ) according to magnetic resonance imaging (MRI). The quality-of-life assessment questionnaires filled out by patients at the hospital stage were studied.
Results.
Pathology of the maxillary system was detected in 90% of patients, which is expressed by complaints of patients with difficulty receiving and combined with TMJ pathology, which, in turn, was asymptomatic in most patients. 70% of the surveyed noted impaired speech and sound formation. It has been established that an increased level of growth hormone for 5 years or more leads to persistent morphological changes in the maxillary system and thereby reduces the quality of life of patients with acromegaly.
Conclusion.
A comprehensive in-depth examination of the dental system in patients with acromegaly makes it possible to diagnose and subsequently comprehensively rehabilitate, while improving the quality of life.

Key words:

acromegaly, orofacial anomalies, growth hormone, insulin-like growth factor

For Citation

[1]
Khasanov A.R., Dzeranova L.K., Pigarova E.A., Melikov E.A., Drobyshev A.Yu. Characteristics of dentofacial anomalies in patients with acromegaly. Clinical Dentistry (Russia).  2026; 29 (1): 164—169. DOI: 10.37988/1811-153X_2026_1_164

References

  1. Perepelova M.A., Lutsenko A.S., Utkina M.V., Tarbaeva N.V., Przhiyalkovskaya E.G. Joint involvement in patients with acromegaly: potential markers for early diagnosis. Obesity and Metabolism. 2024; 2: 195—204 (In Russian). DOI: 10.14341/omet13133
  2. Suojanen J., Hodzic Z., Palotie T., Stoor P. CAD/CAM engineered patient-specific impants as a reposition device in le fort i and modified subcondylar osteotomies: Case report of facial deformity correction in acromegaly. Craniomaxillofac Trauma Reconstr. 2020; 13 (3): 226—236. PMID: 33456692
  3. Adigun O.O., Nguyen M., Fox T.J., Anastasopoulou C. Acromegaly. StatPearls, 2025. PMID: 28613738
  4. Wechsler S. Facial pain and temporomandibular joint dysfunction secondary to acromegaly: Treatment with manual therapy, neuromuscular re-education — A case report. Rehabil Oncol. 2020; 38 (3): 127—133. PMID: 33447472
  5. Al-Hadlaq M., Sroussi H. Acromegaly: Overview and associated temporomandibular joint disorders. Oral Dis. 2024; 30 (6): 3652—3657. PMID: 38225457
  6. Tanaka A., Shoji N., Kojima I., Kumasaka A., Sakamoto M., Sasaki K., Fukunaga T., Mizoguchi I., Tominaga T., Iikubo M. A comparative study on cephalometric differences in maxillofacial morphology between skeletal Class III cases with and without acromegaly: a pilot study. Oral Radiol. 2022; 38 (2): 224—233. PMID: 34245408
  7. Roumeau S., Thevenon J., Ouchchane L., Maqdasy S., Batisse-Lignier M., Duale C., Pham Dang N., Caron P., Tauveron I., Devoize L. Assessment of oro-dental manifestations in a series of acromegalic patients, the AcroDent study. Endocr Connect. 2020; 9 (8): 824—833. PMID: 32738132
  8. Preo G., De Stefani A., Dassie F., Wennberg A., Vettor R., Maffei P., Gracco A., Bruno G. The role of the dentist and orthodontist in recognizing oro-facial manifestations of acromegaly: a questionnaire-based study. Pituitary. 2022; 25 (1): 159—166. PMID: 34518997
  9. De Stefani A., Dassie F., Wennberg A., Preo G., Muneratto A., Fabris R., Maffei P., Gracco A., Bruno G. Oral manifestations and maxillo-facial features in the acromegalic patient: A literature review. J Clin Med. 2022; 11 (4): 1092. PMID: 35207363
  10. Giustina A., Biermasz N., Casanueva F.F., Fleseriu M., Mortini P., Strasburger C., van der Lely A.J., Wass J., Melmed S., Acromegaly Consensus Group Consensus on criteria for acromegaly diagnosis and remission. Pituitary. 2024; 27 (1): 7—22. PMID: 37923946

Received

March 6, 2025

Accepted

March 12, 2026

Published on

March 31, 2026